Combination therapy with nivolumab (anti-PD-1 monoclonal antibody): A new era in tumor immunotherapy-Reference-Cited by-同舟云学术

Combination therapy with nivolumab (anti-PD-1 monoclonal antibody): A new era in tumor immunotherapy

Published:2022-12 Issue: Volume:113 Page:109365
ISSN:1567-5769
Container-title:International Immunopharmacology
language:en
Short-container-title:International Immunopharmacology

Author:

Abedi Kiasari Bahman,Abbasi Arash,Ghasemi Darestani Nadia,Adabi Nasim,Moradian Arsalan,Yazdani Yalda,Sadat Hosseini Golsa,Gholami Nasrin^ORCID,Janati Sheida

Publisher

Elsevier BV

Subject

Pharmacology,Immunology,Immunology and Allergy

Reference250 articles.

1. Intratumoral Delivery of Interferon gamma-secreting MSCs Repolarizes Tumor-Associated Macrophages and Suppresses Neuroblastoma Proliferation In Vivo;Relation,2018

2. HLA-A24 ligandome analysis of colon and lung cancer cells identifies a novel cancer-testis antigen and a neoantigen that elicits specific and strong CTL responses;Kochin;Oncoimmunology,2017

3. Oncology meets immunology: the cancer-immunity cycle;Chen;Immunity,2013

4. Cancer immunoediting: from immunosurveillance to tumor escape;Dunn;Nat. immunol.,2002

5. Complementing the cancer-immunity cycle;Pio;Frontiers in immunol.,2019

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Higher PD-1/Tim-3 expression on IFN-γ+ T cells is associated with poor prognosis in patients with acute myeloid leukemia;Cancer Biology & Therapy;2023-11-14

2. Autophagy as a Target for Non-Immune Intrinsic Functions of Programmed Cell Death-Ligand 1 in Cancer;International Journal of Molecular Sciences;2023-10-09

3. The role of PD-1 signaling in health and immune-related diseases;Frontiers in Immunology;2023-05-16

4. Immune Checkpoint Inhibitor-Based Combination Therapy for Colorectal Cancer: An Overview;International Journal of General Medicine;2023-04

5. The various role of microRNAs in breast cancer angiogenesis, with a special focus on novel miRNA-based delivery strategies;Cancer Cell International;2023-02-10